ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

KURA Kura Oncology Inc

19.00
0.25 (1.33%)
Apr 25 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Kura Oncology Inc KURA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.25 1.33% 19.00 20:00:00
Open Price Low Price High Price Close Price Prev Close
18.15 17.96 19.22 19.00 18.75
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/25/202407:30GLOBEKura Oncology to Report First Quarter 2024 Financial Results
4/22/202407:30GLOBEKura Oncology Receives Breakthrough Therapy Designation for..
4/10/202407:30GLOBEKura Oncology to Participate in Stifel Targeted Oncology..
4/05/202407:30GLOBEKura Oncology Reports Inducement Grants Under Nasdaq Listing..
3/06/202407:30GLOBEKura Oncology Reports First Patient Dosed in Trial of..
3/01/202417:00GLOBEKura Oncology Reports Inducement Grants Under Nasdaq Listing..
2/27/202416:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/27/202416:03EDGAR2Form 8-K - Current report
2/27/202416:01GLOBEKura Oncology Reports Fourth Quarter and Full Year 2023..
2/26/202407:30GLOBEKura Oncology Doses First Patient in KOMET-008 Trial of..
2/22/202407:30GLOBEKura Oncology to Participate in Three Upcoming Investor..
2/20/202407:30GLOBEKura Oncology to Report Fourth Quarter and Full Year 2023..
2/15/202416:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2/15/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
2/14/202417:58EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202417:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/09/202417:21EDGAR2Form S-3 - Registration statement under Securities Act of..
2/02/202407:30GLOBEKura Oncology Reports Inducement Grants Under Nasdaq Listing..
1/31/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/30/202416:10EDGAR2Form 144 - Report of proposed sale of securities
1/30/202407:08EDGAR2Form 8-K - Current report
1/30/202407:00GLOBEKura Oncology Reports Positive Preliminary Ziftomenib..
1/26/202417:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/26/202416:08EDGAR2Form 8-K - Current report
1/24/202416:12EDGAR2Form 144 - Report of proposed sale of securities
1/24/202407:00GLOBEKura Oncology Announces Oversubscribed $150 Million Private..
1/04/202416:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/22/202309:01EDGAR2Form 8-K - Current report
12/11/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/08/202307:30GLOBEKura Oncology’s Menin Inhibitor Ziftomenib Selected for The..
11/28/202307:30GLOBEKura Oncology to Participate in the JMP Securities..
11/02/202316:39EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11/02/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202316:03EDGAR2Form 8-K - Current report
11/02/202316:01GLOBEKura Oncology Reports Third Quarter 2023 Financial Results
11/02/202307:30GLOBEKura Oncology and Mirati Therapeutics Enter into Clinical..
10/30/202307:30GLOBEKura Oncology to Participate in Three Upcoming Investor..
10/26/202316:05GLOBEKura Oncology to Report Third Quarter 2023 Financial Results
10/19/202307:30GLOBEKura Oncology Announces First Patient Dosed in FIT-001 Trial..
10/17/202316:05GLOBEKura Oncology Announces Positive Results from..
10/04/202307:30GLOBEKura Oncology Announces Three Presentations at..
9/28/202307:30GLOBEKura Oncology Reports Preclinical Data Showing Ability of..
9/19/202307:30GLOBEKura Oncology to Participate in Cantor Global Healthcare..

Your Recent History

Delayed Upgrade Clock